Cooper Co.'s (COO) Unit Gets FDA 510(k) Clearance for Avaira Toric Lenses
Tweet
Share
E-mailGet Alerts COO Hot Sheet
Join SI Premium – FREE
The Cooper Companies, Inc. (NYSE: COO) today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric two-week silicone hydrogel contact lenses for astigmatism.
CooperVision will re-launch Avaira Toric with shipments available for select distribution beginning in early May 2012.
CooperVision will re-launch Avaira Toric with shipments available for select distribution beginning in early May 2012.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- CoVolt Power files for proposed IPO
- Lazard Global Total Return fund declares $0.1534 monthly distribution
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
